Didier Renard

2.4k total citations
42 papers, 1.7k citations indexed

About

Didier Renard is a scholar working on Statistics and Probability, Pulmonary and Respiratory Medicine and Management Science and Operations Research. According to data from OpenAlex, Didier Renard has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Statistics and Probability, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Management Science and Operations Research. Recurrent topics in Didier Renard's work include Statistical Methods in Clinical Trials (19 papers), Advanced Causal Inference Techniques (8 papers) and Statistical Methods and Bayesian Inference (7 papers). Didier Renard is often cited by papers focused on Statistical Methods in Clinical Trials (19 papers), Advanced Causal Inference Techniques (8 papers) and Statistical Methods and Bayesian Inference (7 papers). Didier Renard collaborates with scholars based in Belgium, United States and Switzerland. Didier Renard's co-authors include Geert Molenberghs, Helena Geys, Tomasz Burzykowski, Marc Buyse, Philip J. Lowe, Tony Vangeneugden, Annouschka Laenen, Paul Van Royen, Samuel Coenen and B. Michiels and has published in prestigious journals such as Journal of the American College of Cardiology, Biometrics and CHEST Journal.

In The Last Decade

Didier Renard

40 papers receiving 1.7k citations

Peers

Countries citing papers authored by Didier Renard

Since Specialization

Citations

This map shows the geographic impact of Didier Renard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Renard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Renard more than expected).

Fields of papers citing papers by Didier Renard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Renard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Renard. The network helps show where Didier Renard may publish in the future.

Co-authorship network of co-authors of Didier Renard

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Renard. A scholar is included among the top collaborators of Didier Renard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Renard. Didier Renard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial Intelligence for Quantitative Modeling in Drug Discovery and Development: An Innovation and Quality Consortium Perspective on Use Cases and Best Practices 2023 ·Clinical Pharmacology & Therapeutics ·Nadia Terranova, Didier Renard, Mohamed H. Shahin, Sujatha Menon, (unknown), Cornelis E. C. A. Hop, (unknown), (unknown), Sven Stodtmann, Thomas G. Tensfeldt, Pavan Vaddady, (unknown), James Lu	40
2	'ggplot2' Based Tool to Facilitate Diagnostic Plots for NLME Models [R package ggPMX version 1.1.2] 2020 ·(unknown), (unknown), (unknown), (unknown), Christian Bartels, (unknown), (unknown), (unknown), Didier Renard, (unknown), (unknown)	1
3	FIRST-IN-CLASS ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR LCZ696 MODULATES THE DYNAMICS OF THE RENIN CASCADE AND NATRIURETIC PEPTIDES SYSTEM WITH SIGNIFICANT REDUCTION OF ALDOSTERONE EXPOSURE 2014 ·Journal of the American College of Cardiology ·Jonathan P. Mochel, Bryan F. Burkey, Martin Fink, (unknown), Mathieu Peyrou, Jérôme M. Giraudel, Didier Renard, Meindert Danhof	3
4	Reduced Sodium Transport With Nasal Administration of the Prostasin Inhibitor Camostat in Subjects With Cystic Fibrosis 2013 ·CHEST Journal ·Steven M. Rowe, (unknown), Heather Hathorne, (unknown), (unknown), Didier Renard, (unknown), Ping Zhou, Henry Danahay, John Clancy, David Waltz	26
5	A novel model-based approach for dose determination of glycopyrronium bromide in COPD 2012 ·BMC Pulmonary Medicine ·(unknown), Tim Overend, Didier Renard, M.R.J. Gibbs, Vijay Alagappan, Michael Looby, Donald Banerji	30
6	Efficient Algorithms for Optimal Designs with Correlated Observations in Pharmacokinetics and Dose‐Finding Studies 2011 ·Biometrics ·Tim Holland‐Letz, Holger Dette, Didier Renard	6
7	Pharmacokinetics of the Monohydroxy Derivative of Oxcarbazepine and Its Enantiomers after a Single Intravenous Dose Given as Racemate Compared with a Single Oral Dose of Oxcarbazepine 2011 ·Drug Metabolism and Disposition ·Gérard Flesch, (unknown), Didier Renard, Peter Lloyd	35
8	Pharmacokinetics of multiple inhaled NVA237 doses in patients with chronic obstructive pulmonary disease (COPD) 2011 ·International Journal of Clinical Pharmacology and Therapeutics ·Romain Séchaud, Didier Renard, (unknown), Stephan de la Motte, Anton Drollmann, (unknown)	28
9	Joint detection of important biomarkers and optimal dose–response model using penalties 2007 ·Statistics in Medicine ·(unknown), Paul H.C. Eilers, Edouard Ledent, Didier Renard, Fabián Tibaldi	3
10	Conditional mixed models with crossed random effects 2006 ·British Journal of Mathematical and Statistical Psychology ·Fabián Tibaldi, Geert Verbeke, Geert Molenberghs, Didier Renard, Wim Van Den Noortgate, Paul De Boeck	8
11	Applying Concepts of Generalizability Theory on Clinical Trial Data to Investigate Sources of Variation and Their Impact on Reliability 2005 ·Biometrics ·Tony Vangeneugden, Annouschka Laenen, Helena Geys, Didier Renard, Geert Molenberghs	93
12	Joint modelling of repeated measurements and event time: Application to performance traits and survival of lambs bred in sub-humid tropics 2005 ·Genetics Selection Evolution ·Rosemary Nguti, Tomasz Burzykowski, (unknown), Didier Renard, Paul Janssen	4
13	Applying linear mixed models to estimate reliability in clinical trial data with repeated measurements 2004 ·Controlled Clinical Trials ·Tony Vangeneugden, Annouschka Laenen, Helena Geys, Didier Renard, Geert Molenberghs	60
14	Prentice's Approach and the Meta‐Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints 2004 ·Biometrics ·Ariel Alonso, Geert Molenberghs, Tomasz Burzykowski, Didier Renard, Helena Geys, Ziv Shkedy, Fabián Tibaldi, José Cortiñas Abrahantes, Marc Buyse	46
15	Design-based analysis of surveys: a bovine herpesvirus 1 case study 2003 ·Epidemiology and Infection ·Niko Speybroeck, Frank Boelaert, Didier Renard, Tomasz Burzykowski, Koen Mintiens, Geert Molenberghs, Dirk Berkvens	10
16	Statistical challenges in the evaluation of surrogate endpoints in randomized trials 2002 ·Controlled Clinical Trials ·Geert Molenberghs, Marc Buyse, Helena Geys, Didier Renard, Tomasz Burzykowski, Ariel Alonso	79
17	Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points 2001 ·Journal of the Royal Statistical Society Series C (Applied Statistics) ·Tomasz Burzykowski, Geert Molenberghs, Marc Buyse, Helena Geys, Didier Renard	150
18	Repeated‐measures models to evaluate a hepatitis B vaccination programme 2001 ·Statistics in Medicine ·Didier Renard, Liesbeth Bruckers, Geert Molenberghs, Akke Vellinga, Pierre Van Damme	8
19	The validation of surrogate endpoints in meta-analyses of randomized experiments 2000 ·Biostatistics ·Marc Buyse, Geert Molenberghs, Tomasz Burzykowski, Didier Renard, Helena Geys	428
20	Release of cardiac troponin I in antegrade crystalloid versus cold blood cardioplegia 1999 ·Journal of Thoracic and Cardiovascular Surgery ·Marc Hendrikx, (unknown), (unknown), (unknown), Didier Renard, (unknown), (unknown), Urbain Mees	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact